产品中心Cell Resources
联系我们CONTACT US
400-999-210024小时服务热线
产品概述
名称 | A2780 (人卵巢癌细胞)(暂不出售) |
别称 | A-2780; 2780; A2780S |
种属 | 人 |
生长特性 | 贴壁细胞 |
细胞形态 | 上皮细胞样 |
生长培养基 | DMEM+10% FBS+1% P/S |
冻存条件 | 冻存液:55% 基础培养基+40%FBS+5%DMSO 温度:液氮 |
培养条件 | 气相:空气,95%;CO2,5% 温度:37℃ |
推荐传代比例 | 1:3-1:4 |
推荐换液频率 | 2~3次/周 |
组织来源 | 皮肤 |
细胞类型 | 肿瘤细胞 |
肿瘤类型 | 卵巢癌细胞 |
生物安全等级 | 1 |
倍增时间 | ~16 hours |
保藏机构 | ECACC; 93112519 |
参考文献
-
Tumor-secreted anterior gradient-2 binds to VEGF and FGF2 and enhances their activities by promoting their homodimerization(2017/05/08)
作者:H Guo, Q Zhu, X Yu
期刊:Oncogene
影响因子 :8.000
-
Naringenin suppresses epithelial ovarian cancer by inhibiting proliferation and modulating gut microbiota(2022/08/19)
作者:Caiji Lin, Zheng Zeng, Yiru Lin
期刊:PHYTOMEDICINE
DOI:10.1016/j.phymed.2022.154401
影响因子 :7.900
-
Knockdown of long non-coding RNA HOTAIR reverses cisplatin resistance of ovarian cancer cells through inhibiting miR-138-5p-regulated EZH2 and SIRT1(2020/4/29)
作者:Yun Zhang, Hao Ai, Xue Fan
期刊:Biological Research
DOI:10.1186/s40659-020-00286-3
影响因子 :6.700
-
Inhibition of STX17–SNAP29–VAMP8 complex formation by costunolide sensitizes ovarian cancer cells to cisplatin via the AMPK/mTOR signaling pathway(2023/04/13)
作者:Xiao Liang, Chunlei Yu, Yunhong Tian
期刊:BIOCHEMICAL PHARMACOLOGY
影响因子 :5.800
引用产品:CL-0013
-
LncRNA KCNQ1OT1 promotes the metastasis of ovarian cancer by increasing the methylation of EIF2B5 promoter(2022/09/13)
作者:Sili He, Yaling Chen, Qihua Chen
期刊:MOLECULAR MEDICINE
DOI:10.1186/s10020-022-00521-5
影响因子 :5.700
-
P76RBE silencing inhibits ovarian cancer cell proliferation, migration, and invasion via suppressing the integrin β1/NF-κB pathway(2021/08/12)
作者:Limei Yan, Zeping He, Wei Li
期刊:Cell Cycle
DOI:10.1080/15384101.2021.1963910
影响因子 :5.173
引用产品:CL-0013 CL-0178 CL-0215 CL-0626 CM-0178 CM-0626 CM-H055 CP-H055
-
Knockdown of lncRNA ACTA2-AS1 reverses cisplatin resistance of ovarian cancer cells via inhibition of miR-378a-3p-regulated Wnt5a(2022/04/12)
作者:Chenxiao Lin, Meiyun Zheng, Youlin Yang
期刊:Bioengineered
DOI:10.1080/21655979.2022.2061181
影响因子 :4.900
-
CircLNPEP promotes the progression of ovarian cancer through regulating miR-876-3p/ WNT5A axis(2021/08/31)
作者:Wenwen Wang, Weiwei Zhang, Hongjun Guo
期刊:Cell Cycle
DOI:10.1080/15384101.2021.1965723
影响因子 :4.300
-
Mangiferin induces apoptosis in human ovarian adenocarcinoma OVCAR3 cells via the regulation of Notch3(2017/7/13)
作者:Bingyu Zou, Hailian Wang, Yilong Liu
期刊:Oncology Reports
影响因子 :4.200
引用产品:CL-0013
-
Knockdown of heat shock protein family D member 1 (HSPD1) promotes proliferation and migration of ovarian cancer cells via disrupting the stability of mitochondrial 3-oxoacyl-ACP synthase (OXSM)(2023/04/22)
作者:Yaoyun Duan, Juan Yu, Miaojuan Chen
期刊:Journal of Ovarian Research
DOI:10.1186/s13048-023-01156-8
影响因子 :4.000
-
CircSETDB1 knockdown inhibits the malignant progression of serous ovarian cancer through miR-129-3p-dependent regulation of MAP3K3(2021/11/17)
作者:Bo Li, Lu Zhang
期刊:Journal of Ovarian Research
DOI:10.1186/s13048-021-00875-0
影响因子 :4.000
-
Curcumin inhibits ovarian cancer progression by regulating circ-PLEKHM3/miR-320a/SMG1 axis(2021/11/16)
作者:Sifan Sun, Hailiang Fang
期刊:Journal of Ovarian Research
DOI:10.1186/s13048-021-00916-8
影响因子 :4.000
-
CCNG1 (Cyclin G1) regulation by mutant‐P53 via induction of Notch3 expression promotes high‐grade serous ovarian cancer (HGSOC) tumorigenesis and progression(2018/12/18)
作者:Ying Xu, Qing Zhang, Chunying Miao
期刊:Cancer Medicine
影响因子 :4.000
引用产品:CL-0013
-
Main components of pomegranate, ellagic acid and luteolin, inhibit metastasis of ovarian cancer by down-regulating MMP2 and MMP9(2017/11/27)
作者:Huidi Liu, Zheng Zeng, Siwen Wang
期刊:Cancer Biology & Therapy
DOI:10.1080/15384047.2017.1394542
影响因子 :3.600
-
Dihydroartemisinin regulates apoptosis, migration, and invasion of ovarian cancer cells via mediating RECK(2021/3/13)
作者:Jingfei Zheng, Xuehe Li, Weili Yang
期刊:Journal Of Pharmacological Sciences
DOI:10.1016/j.jphs.2021.02.001
影响因子 :3.500
引用产品:CL-0013
-
MiR-34a-5p/PD-L1 axis regulates cisplatin chemoresistance of ovarian cancer cells(2019/12/26)
作者:Y Zuo, W Zheng, J Liu
期刊:Neoplasma
DOI:10.4149/neo_2019_190202N106
影响因子 :3.409
-
LPA3 is a precise therapeutic target and potential biomarker for ovarian cancer(2022/01/04)
作者:Pengfei Zhao, Qingru Yun, Aodungerile Li
期刊:Medical Oncology
DOI:10.1007/s12032-021-01616-5
影响因子 :3.400
-
IQGAP3 promotes cancer proliferation and metastasis in high‑grade serous ovarian cancer(2020/5/21)
作者:Samina Dongol, Qing Zhang, Chunping Qiu
期刊:Oncology Letters
影响因子 :2.900
引用产品:CL-0013
-
miR‑638 suppresses proliferation by negatively regulating high mobility group A1 in ovarian cancer cells(2021/9/20)
作者:Li Ma, Wei Zhang, Yaofeng Jin
期刊:Experimental and Therapeutic Medicine
影响因子 :2.700
-
Circ_0021573 acts as a competing endogenous RNA to promote the malignant phenotypes of human ovarian cancer cells(2022/12/05)
作者:Lifang Liu, Bingkai Han, Lixia Liu
期刊:Reproductive Biology
DOI:10.1016/j.repbio.2022.100704
影响因子 :2.100
引用产品:164210 164210-50 CL-0005 CL-0013 CL-0079 CL-0178 CL-0215 PB180120 PM150110
-
基于气相色谱 质谱的代谢组学技术研究紫杉醇诱导的卵巢癌 A2780耐药株的生物标志物(2016/01)
作者:崔广波, 刘晓昕
期刊:南京工业大学学报
DOI:10.3969/j.issn.1671-7627.2016.01.018
影响因子 :0.370
引用产品:CL-0013
-
PHGDH Inhibitor CBR-5884 Inhibits Epithelial Ovarian Cancer Progression via ROS/Wnt/β-Catenin Pathway and Plays a Synergistic Role with PARP Inhibitor Olaparib(2022/09/05)
作者:Xiaocui Zhang, Meige Sun, Yisheng Jiao
期刊:Oxidative Medicine and Cellular Longevity
影响因子 :0.000
引用产品:164210 164210-50 CL-0013 CL-0079 CL-0178 P-CA-161 PM150110 PM150710